The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor - Concepedia

Concepedia

Publication | Open Access

The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor

DOI Full Paper Access

426

Citations

15

References

1999

Year

Petpiboon Prasit, Z Wang, Christine Brideau, Chi‐Chung Chan, S. Charleson, Wanda Cromlish, Diane Ethier, Jilly F. Evans, A W Ford‐Hutchinson, J. Y. GAUTHIER,

Bioorganic & Medicinal Chemistry Letters

Molecular PharmacologyMedicinal ChemistryActive Cyclooxygenase-2 InhibitorPharmaceutical ScienceBiochemistryMedicineNatural SciencesPharmacotherapyDrug DevelopmentPharmacologyPharmaceutical ChemistryDrug DiscoveryDrug Resistance

References

	Year	Citations

Page 1

Page 1